Formula: C1105H1770N318O336S26

Description: HUCOG HCG (Human Chorionic Gonadotropin) is a pharmaceutical product primarily used in the treatment of infertility in both men and women. It contains highly purified human chorionic gonadotropin hormone, which is naturally produced during pregnancy. HUCOG HCG is available in various forms, including injections and sublingual tablets, and is prescribed under medical supervision.

Composition: HUCOG HCG contains highly purified human chorionic gonadotropin (hCG) hormone as its active ingredient. The composition may vary depending on the specific formulation and dosage strength.

Uses: HUCOG HCG is used for various medical purposes, including:

1. Stimulating ovulation in women undergoing assisted reproductive techniques such as in vitro fertilization (IVF) or intrauterine insemination (IUI).
2. Treating infertility in men by stimulating the production of testosterone and sperm production.
3. Managing cryptorchidism (undescended testes) in young boys.
4. Treating delayed puberty in adolescent boys.

Usage and Dosage: The usage and dosage of HUCOG HCG depend on the specific indication, patient’s medical condition, and the healthcare provider’s recommendation. It is administered via injection or sublingual tablets, typically following a specific dosing regimen tailored to individual needs.

Storage Conditions: HUCOG HCG should be stored according to the manufacturer’s instructions, typically in a cool, dry place, away from direct sunlight, and at a controlled room temperature. Proper storage helps maintain the stability and effectiveness of the product.

Mechanism of Action: Human chorionic gonadotropin (hCG) in HUCOG HCG acts similarly to luteinizing hormone (LH) in the body. In women, it stimulates the release of mature eggs from the ovaries during ovulation. In men, it mimics the action of LH to stimulate testosterone production in the testes, which in turn promotes sperm production.

Contraindications: HUCOG HCG is contraindicated in individuals with a known hypersensitivity to human chorionic gonadotropin or any components of the formulation. It should not be used in cases of precocious puberty, prostatic carcinoma, or androgen-dependent tumors.

Adverse Reactions: Common adverse reactions associated with HUCOG HCG may include injection site reactions, headache, fatigue, breast tenderness, and mood changes. It is important for patients to report any unusual or severe side effects to their healthcare provider.

Patients should consult with their healthcare provider for personalized information regarding the use of HUCOG HCG, as individual responses to medication can vary. Proper medical supervision is essential for safe and effective treatment.